Welcome to the e-CCO Library!

P036 A novel p53-mediated mouse model of inflammatory bowel disease-associated colorectal cancer
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.M. Churchhouse1, C.V. Billard1, M.J. Arends2, K.B. Myant1

Created: Thursday, 30 January 2020, 10:12 AM
P036: Analysis of intestinal tissue from newly diagnosed patients with inflammatory bowel disease reveals distinct proteomic profiles
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Baldan-Martin, M.(1)*;Lloro, I.(2);Azkargorta, M.(2);Ramírez, C.(1);Soleto Fernández, I.(1);Orejudo, M.(1);García, S.(1);Mercado, J.(1);Gordillo, C.H.(3);Riestra, S.(4);Rivero, M.(5);Gutiérrez, A.(6);Rodríguez-Lago, I.(7);Fernández-Salazar, L.(8);Ceballos, D.(9);Benítez, J.M.(10);Aguas, M.(11);Bastón-Rey, I.(12);Bermejo, F.(13);Casanova, M.J.(1);Lorente, R.(14);Ber, Y.(15);Royo, V.(16);Esteve, M.(17);Elortza, F.(2);Gisbert, J.P.(1);Chaparro, M.(1);
Created: Friday, 14 July 2023, 10:48 AM
P036: Colon targeted delivery of tofacitinib inhibits oxazolone-induced colitis in mice, despite low systemic exposure
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

F. Shen*, P. Brassil, S. Hegde, D. Beattie

Created: Friday, 22 February 2019, 9:49 AM
P036: Expression of CD69 on peripheral lymphocytes predicts treatment response in Acute Severe ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. C. Choy*1,2,3, J. Yu2, M. Congiu2, P. Pelpola2, J. Nigro2, R. Burder1, K. Boyd1, M. McGuckin4, A. J. Corbett5, L. Kjer-Nielsen5, J. McCluskey5, K. Visvanathan2, P. De Cruz1,3

Created: Friday, 22 February 2019, 9:41 AM
P036: Faecalibacterium prausnitzii produces butyrate to maintain Th17/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Zhou1*, M. Zhang1,2,3, Y. Wang1, T. Yu1,4, X. Chen1, D. Tang1, L. Xu1, Y. Yin1, Y. Pan5, Q. Zhou6, Y. Zhou1, C. Yu1,2

Created: Thursday, 21 February 2019, 9:14 AM
P036: Human peripheral blood monocytes and intestinal macrophage populations activate transforming growth factor beta via expression of the integrin alpha v beta 8
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Shuttleworth E.*1,2,3, Kelly A.1,2,3, Fenton T.1,2,3, Smedley C.1,2,3, Levison S.4, Travis M.1,2,3

Created: Wednesday, 20 February 2019, 10:36 AM
P036: Identification and functional analysis of stromal subsets in experimental IBD mouse models
Year: 2022
Source: ECCO'22
Authors: Zhou, Z.(1);Plug, L.G.(1);de Jonge-Muller, E.S.M.(1);van de Beek, L.M.(1);Brands, L.(1);van der Meulen-de Jong, A.E.(1);Hawinkels, L.J.A.C.(1);Barnhoorn, M.C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P036: MicroRNA composition of colon crypt-top and crypt-bottom epithelial cells in Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Inčiūraitė, R.(1);Juzėnas, S.(1,2);Ramonaitė, R.(1);Skiecevičienė, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P037 Antagonism of chemokine receptor CCR9 synergises with anti-TNFα immunotherapy to reduce inflammation in the MDR1a−/− mouse model of colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Campbell1, L. Ertl1, K. Ebsworth1, J. McMahon2, P. Zhang2, V. Chhina1, I. Charo1, T. Schall1

Created: Thursday, 30 January 2020, 10:12 AM
P037: Bacterial handling defect in macrophages of patients with defects in glucose-6-phosphate metabolism and Crohn’s disease like intestinal inflammation
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Pandey1*, K. Balagopal1, D. Aschenbrenner1, M. Capitani1, C. Weidinger2, E. Pires3, J. McCullagh3, S. Travis1, J. Ziegler2, B. Siegmund2, H.H. Uhlig1

Created: Thursday, 21 February 2019, 9:14 AM
P037: Enhancing the efficacy of cannabidiol using protein nanoparticles to treat inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Moniruzzaman, M.(1,2)*;Rewatkar, P.(1);Begun, J.(2);Popat, A.(1);
Created: Friday, 14 July 2023, 10:48 AM
P037: MDR1-deficiency unmasks mitochondrial dysfunction as a pathogenic mechanism in IBD
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ho G.-T.*1, Aird R.1, Boyapati R.1, Liu B.2, Kennedy N.1, Shimizu T.3, Sartor B.2, Satsangi J.1

Created: Wednesday, 20 February 2019, 10:36 AM
P037: MicroRNA-31 and microRNA-200 family reflect disease activity in Crohn’s disease: results from the BIOMIR study
Year: 2022
Source: ECCO'22
Authors: Cristina, T.(1);Mateescu, B.(2);Mitroi, A.(3);Cozaru, G.(3);Brinzan, C.(3);State, M.(2);Dumitru, A.(1);Rafti, R.(1);Dina, E.(1);Alexandrescu, L.(1);Dumitru, E.(1);
Created: Friday, 11 February 2022, 3:52 PM
P037: Nonclinical pharmacokinetics and absorption, distribution, metabolism, and excretion properties of MORF-057 support its clinical development as an oral selective α4β7 integrin inhibitor
Year: 2021
Source: ECCO'21 Virtual
Authors: Jones, J.(1);Lee, D.(1);Smukste, I.(1);Cui, D.(1);Bursavich, M.G.(2);Troast, D.(2);Zhong, C.(2);Wong , J.E.(3);Mangada, M.M.(3);Bain, G.(3);Lippa, B.(2);Ray, A.S.(3);Rogers, B.N.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P037: Remodelling events preceding clinical onset of intestinal inflammation reveal the predictive power of the extracellular matrix
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

E. Shimshoni*1, R. Afik1, L. Puricelli2, A. Shenoy3, T. Geiger3, A. Podestà2, I. Sagi1

Created: Friday, 22 February 2019, 9:49 AM
P037: USP16-mediated deubiquitination of calcineurin A controls peripheral T cells maintenance and attenuates intestinal inflammation
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

Y. Zhang*1,2, R. Liu1,2, K. Fan3, L. Huang1,2, Z. Gao3, T. Huang3, J. Zhong3, X. Mao3, X. Mao3, F. Wang3, P. Xiao1,2, Y. Zhao1,2, Y. Li3, X. Feng3, J. Jin3, Q. Cao1,2

Created: Friday, 22 February 2019, 9:41 AM
P038 A single-cell transcriptomics approach reveals high-resolution cellular signatures in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Garrido Trigo1, A.M. Corraliza1, M. Veny1, J. Lozano2, E. Ricart3, I. Ordás3, M.C. Masamunt3, J. Panés3, M. Hemberg4, A. Salas1

Created: Thursday, 30 January 2020, 10:12 AM
P038: Expression analysis in colitis-associated carcinoma: a role for osteopontin?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

D. Cardoso da Silva*1, M. Sehn2, S. Elezkurtaj3, A. Kühl4, B. Siegmund1, M. Kreis2, C. Holmer2, M. Hummel3, J. Gröne5, M. Schumann1

Created: Friday, 22 February 2019, 9:41 AM
P038: Microbial regulation of T-cell fate towards regulatory profiles during T-cell transfer induced colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Machicote, A.(1);Pelczar, P.(1);Nawrocki , M.(1);Fazio, A.(1);Liu , B.(1);Kopplin, L.(2);Wende, M.(3);Indenbirken, D.(4);Pabst, O.(2);Strowig, T.(3);Gagliani, N.(5);Huber, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P038: Notch pathway in fibrosis: a new anti-fibrotic therapy in Crohn's disease?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Marti-Chafer, S.(1);Jimenez-Mallen, E.(1);Mendoza, T.(1);Macias-Ceja, D.C.(2);Bauset, C.(2)*;Seco-Cervera, M.(3);Calatayud, S.(4);Cosin-Roger, J.(4);Barrachina, M.D.(4);Ortiz-Masiá, D.(5);
Created: Friday, 14 July 2023, 10:48 AM